Stella Pharma Corporation (TYO:4888)

Japan · Delayed Price · Currency is JPY

313.00

-2.00 (-0.63%)

Aug 6, 2026, 11:30 AM JST

Stella Pharma Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	323	323	961	269	229	100
Revenue Growth	-66.39%	-66.39%	257.25%	17.47%	129.00%	-51.22%
Gross Profit	279	279	845	217	207	85
Operating Income	-749	-749	-90	-760	-806	-741
Net Income	-780	-780	-140	-763	-778	-767
Earnings Per Share	-22.93	-22.93	-4.19	-24.63	-26.94	-27.31
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
China	629.97	-	-	-	-
Japan	331.09	269.49	229.07	100.1	205.97

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	2,823	2,823	3,206	2,352	2,710	3,276
Total Debt	746	746	766	933	1,093	1,253
Net Cash (Debt)	2,077	2,077	2,440	1,419	1,617	2,023
Net Cash Growth	-14.88%	-14.88%	71.95%	-12.25%	-20.07%	-
Net Cash Per Share	61.05	61.05	73.10	45.81	56.00	72.04

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-334	-334	140	-876	-827	-1,081
Capital Expenditures	-11	-11	-4	-10	-26	-46
Free Cash Flow	-345	-345	136	-886	-853	-1,127
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	86.38%	86.38%	87.93%	80.67%	90.39%	85.00%
Operating Margin	-231.89%	-231.89%	-9.37%	-282.53%	-351.96%	-741.00%
Pretax Margin	-240.87%	-240.87%	-14.36%	-282.90%	-338.86%	-764.00%
Profit Margin	-241.49%	-241.49%	-14.57%	-283.64%	-339.74%	-767.00%
FCF Margin	-106.81%	-106.81%	14.15%	-329.37%	-372.49%	-1127.00%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
P/FCF Ratio	-	-	95.85	-	-	-
PS Ratio	35.14	79.97	13.56	33.78	50.15	172.82